Unknown

Dataset Information

0

Contribution of pks+ E. coli mutations to colorectal carcinogenesis.

ABSTRACT: The dominant mutational signature in colorectal cancer genomes is C > T deamination (COSMIC Signature 1) and, in a small subgroup, mismatch repair signature (COSMIC signatures 6 and 44). Mutations in common colorectal cancer driver genes are often not consistent with those signatures. Here we perform whole-genome sequencing of normal colon crypts from cancer patients, matched to a previous multi-omic tumour dataset. We analyse normal crypts that were distant vs adjacent to the cancer. In contrast to healthy individuals, normal crypts of colon cancer patients have a high incidence of pks + (polyketide synthases) E.coli (Escherichia coli) mutational and indel signatures, and this is confirmed by metagenomics. These signatures are compatible with many clonal driver mutations detected in the corresponding cancer samples, including in chromatin modifier genes, supporting their role in early tumourigenesis. These results provide evidence that pks + E.coli is a potential driver of carcinogenesis in the human gut.

SUBMITTER: Chen B 

PROVIDER: S-EPMC10687070 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Contribution of pks<sup>+</sup> E. coli mutations to colorectal carcinogenesis.

Chen Bingjie B   Ramazzotti Daniele D   Heide Timon T   Spiteri Inmaculada I   Fernandez-Mateos Javier J   James Chela C   Magnani Luca L   Graham Trevor A TA   Sottoriva Andrea A  

Nature communications 20231129 1

The dominant mutational signature in colorectal cancer genomes is C > T deamination (COSMIC Signature 1) and, in a small subgroup, mismatch repair signature (COSMIC signatures 6 and 44). Mutations in common colorectal cancer driver genes are often not consistent with those signatures. Here we perform whole-genome sequencing of normal colon crypts from cancer patients, matched to a previous multi-omic tumour dataset. We analyse normal crypts that were distant vs adjacent to the cancer. In contras  ...[more]